JP2012531428A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012531428A5 JP2012531428A5 JP2012517737A JP2012517737A JP2012531428A5 JP 2012531428 A5 JP2012531428 A5 JP 2012531428A5 JP 2012517737 A JP2012517737 A JP 2012517737A JP 2012517737 A JP2012517737 A JP 2012517737A JP 2012531428 A5 JP2012531428 A5 JP 2012531428A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- separation matrix
- solution
- refolding
- washing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 27
- 108090000623 proteins and genes Proteins 0.000 claims 19
- 102000004169 proteins and genes Human genes 0.000 claims 19
- 235000018102 proteins Nutrition 0.000 claims 18
- 239000011159 matrix material Substances 0.000 claims 14
- 238000000926 separation method Methods 0.000 claims 13
- 239000000243 solution Substances 0.000 claims 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 6
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 claims 6
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims 5
- 239000011347 resin Substances 0.000 claims 5
- 229920005989 resin Polymers 0.000 claims 5
- 238000005406 washing Methods 0.000 claims 5
- 239000003638 chemical reducing agent Substances 0.000 claims 4
- 230000008929 regeneration Effects 0.000 claims 4
- 238000011069 regeneration method Methods 0.000 claims 4
- 108010024636 Glutathione Proteins 0.000 claims 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 3
- 239000007983 Tris buffer Substances 0.000 claims 3
- 239000004202 carbamide Substances 0.000 claims 3
- 239000013592 cell lysate Substances 0.000 claims 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 3
- 235000018417 cysteine Nutrition 0.000 claims 3
- 239000003398 denaturant Substances 0.000 claims 3
- 239000004475 Arginine Substances 0.000 claims 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 2
- RYECOJGRJDOGPP-UHFFFAOYSA-N Ethylurea Chemical compound CCNC(N)=O RYECOJGRJDOGPP-UHFFFAOYSA-N 0.000 claims 2
- 108091006020 Fc-tagged proteins Proteins 0.000 claims 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 2
- MGJKQDOBUOMPEZ-UHFFFAOYSA-N N,N'-dimethylurea Chemical compound CNC(=O)NC MGJKQDOBUOMPEZ-UHFFFAOYSA-N 0.000 claims 2
- XGEGHDBEHXKFPX-UHFFFAOYSA-N N-methylthiourea Natural products CNC(N)=O XGEGHDBEHXKFPX-UHFFFAOYSA-N 0.000 claims 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 2
- 239000002202 Polyethylene glycol Substances 0.000 claims 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 2
- 229930006000 Sucrose Natural products 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 230000002776 aggregation Effects 0.000 claims 2
- 238000004220 aggregation Methods 0.000 claims 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 2
- 239000000872 buffer Substances 0.000 claims 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 2
- 239000008103 glucose Substances 0.000 claims 2
- 229960003180 glutathione Drugs 0.000 claims 2
- 239000003112 inhibitor Substances 0.000 claims 2
- 239000002563 ionic surfactant Substances 0.000 claims 2
- 230000002934 lysing effect Effects 0.000 claims 2
- 210000004962 mammalian cell Anatomy 0.000 claims 2
- XGEGHDBEHXKFPX-NJFSPNSNSA-N methylurea Chemical compound [14CH3]NC(N)=O XGEGHDBEHXKFPX-NJFSPNSNSA-N 0.000 claims 2
- 239000002736 nonionic surfactant Substances 0.000 claims 2
- 230000003204 osmotic effect Effects 0.000 claims 2
- 229920001223 polyethylene glycol Polymers 0.000 claims 2
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 claims 2
- 229910052939 potassium sulfate Inorganic materials 0.000 claims 2
- 235000011151 potassium sulphates Nutrition 0.000 claims 2
- 229940124272 protein stabilizer Drugs 0.000 claims 2
- 229910052938 sodium sulfate Inorganic materials 0.000 claims 2
- 235000011152 sodium sulphate Nutrition 0.000 claims 2
- 238000005063 solubilization Methods 0.000 claims 2
- 230000007928 solubilization Effects 0.000 claims 2
- 230000003381 solubilizing effect Effects 0.000 claims 2
- 239000000600 sorbitol Substances 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 239000005720 sucrose Substances 0.000 claims 2
- 150000005846 sugar alcohols Polymers 0.000 claims 2
- 239000004094 surface-active agent Substances 0.000 claims 2
- 210000005253 yeast cell Anatomy 0.000 claims 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 claims 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims 1
- 108010053070 Glutathione Disulfide Proteins 0.000 claims 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical class NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims 1
- 101710120037 Toxin CcdB Proteins 0.000 claims 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 1
- -1 antibodies Proteins 0.000 claims 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- OOTFVKOQINZBBF-UHFFFAOYSA-N cystamine Chemical compound CCSSCCN OOTFVKOQINZBBF-UHFFFAOYSA-N 0.000 claims 1
- 229940099500 cystamine Drugs 0.000 claims 1
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 claims 1
- 229960002433 cysteine Drugs 0.000 claims 1
- 229960003067 cystine Drugs 0.000 claims 1
- 238000010828 elution Methods 0.000 claims 1
- YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 claims 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-O guanidinium Chemical compound NC(N)=[NH2+] ZRALSGWEFCBTJO-UHFFFAOYSA-O 0.000 claims 1
- 230000002209 hydrophobic effect Effects 0.000 claims 1
- 210000003000 inclusion body Anatomy 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 239000003456 ion exchange resin Substances 0.000 claims 1
- 229920003303 ion-exchange polymer Polymers 0.000 claims 1
- 229960003151 mercaptamine Drugs 0.000 claims 1
- YPZRWBKMTBYPTK-UHFFFAOYSA-N oxidized gamma-L-glutamyl-L-cysteinylglycine Natural products OC(=O)C(N)CCC(=O)NC(C(=O)NCC(O)=O)CSSCC(C(=O)NCC(O)=O)NC(=O)CCC(N)C(O)=O YPZRWBKMTBYPTK-UHFFFAOYSA-N 0.000 claims 1
- 229940016590 sarkosyl Drugs 0.000 claims 1
- 108700004121 sarkosyl Proteins 0.000 claims 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 claims 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22047709P | 2009-06-25 | 2009-06-25 | |
| US61/220,477 | 2009-06-25 | ||
| PCT/US2010/039854 WO2010151688A2 (en) | 2009-06-25 | 2010-06-24 | Capture purification processes for proteins expressed in a non-mammalian system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012531428A JP2012531428A (ja) | 2012-12-10 |
| JP2012531428A5 true JP2012531428A5 (https=) | 2013-08-08 |
Family
ID=43242573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012517737A Pending JP2012531428A (ja) | 2009-06-25 | 2010-06-24 | 哺乳類以外の系で発現されるタンパク質の捕獲精製プロセス |
Country Status (12)
| Country | Link |
|---|---|
| US (5) | US8940878B2 (https=) |
| EP (2) | EP3660032B1 (https=) |
| JP (1) | JP2012531428A (https=) |
| AU (1) | AU2010266093B2 (https=) |
| CA (1) | CA2765154A1 (https=) |
| DK (1) | DK3660032T3 (https=) |
| ES (2) | ES3056593T3 (https=) |
| FI (1) | FI3660032T3 (https=) |
| LT (1) | LT3660032T (https=) |
| MX (1) | MX2011013417A (https=) |
| SI (1) | SI3660032T1 (https=) |
| WO (1) | WO2010151688A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA020621B1 (ru) | 2009-06-22 | 2014-12-30 | Амген Инк. | Рефолдинг белков с использованием химически контролируемого окислительно-восстановительного состояния |
| LT3660032T (lt) | 2009-06-25 | 2026-02-25 | Amgen Inc. | Ne žinduolių sistemoje ekspresuotų baltymų surišamojo gryninimo būdai |
| WO2011109556A2 (en) | 2010-03-04 | 2011-09-09 | Pfenex Inc. | Method for producing soluble recombinant interferon protein without denaturing |
| GB201506870D0 (en) | 2015-04-22 | 2015-06-03 | Ucb Biopharma Sprl | Method |
| US20170101435A1 (en) * | 2015-10-13 | 2017-04-13 | Therapeutic Proteins International, LLC | Harvesting and perfusion apparatus |
| CA3218290A1 (en) * | 2016-07-22 | 2018-01-25 | Amgen Inc. | Methods of purifying fc-containing proteins |
| WO2019040671A1 (en) * | 2017-08-22 | 2019-02-28 | Biogen Ma Inc. | METHODS OF PURIFYING ANTIBODIES HAVING REDUCED AGGREGATES OF HIGH MOLECULAR WEIGHT |
| US11051532B2 (en) | 2017-09-22 | 2021-07-06 | Impossible Foods Inc. | Methods for purifying protein |
| CN112839959A (zh) * | 2018-09-21 | 2021-05-25 | 特尼奥生物股份有限公司 | 用于纯化异源二聚多特异性抗体的方法 |
| US12011016B2 (en) | 2020-09-14 | 2024-06-18 | Impossible Foods Inc. | Protein methods and compositions |
| PL4263568T3 (pl) | 2020-12-18 | 2025-11-24 | Richter Gedeon Nyrt. | Sposoby oczyszczania poddanego ponownemu fałdowaniu białka fuzyjnego peptydu Fc |
Family Cites Families (81)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4468464A (en) | 1974-11-04 | 1984-08-28 | The Board Of Trustees Of The Leland Stanford Junior University | Biologically functional molecular chimeras |
| US4237224A (en) | 1974-11-04 | 1980-12-02 | Board Of Trustees Of The Leland Stanford Jr. University | Process for producing biologically functional molecular chimeras |
| WO1984003711A1 (en) | 1983-03-25 | 1984-09-27 | Celltech Ltd | A process for the production of a protein |
| US4468454A (en) | 1983-06-10 | 1984-08-28 | E. I. Du Pont De Nemours And Company | Antifoggant process |
| US4572798A (en) | 1984-12-06 | 1986-02-25 | Cetus Corporation | Method for promoting disulfide bond formation in recombinant proteins |
| GB8508340D0 (en) | 1985-03-29 | 1985-05-09 | Creighton T E | Production of protein |
| US4810643A (en) | 1985-08-23 | 1989-03-07 | Kirin- Amgen Inc. | Production of pluripotent granulocyte colony-stimulating factor |
| CA1339757C (en) | 1987-04-16 | 1998-03-17 | Robert F. Halenbeck | Production of purified biologically active, bacterially produced recombinant human csf-1 |
| IL86090A (en) | 1987-04-16 | 1993-03-15 | Cetus Oncology Corp | Production of purified, biologically active, bacterially produced recombinant human csf-1 |
| CA1329119C (en) | 1988-03-29 | 1994-05-03 | Milton David Goldenberg | Cytotoxic therapy |
| JP2796388B2 (ja) | 1988-05-13 | 1998-09-10 | アムジエン・インコーポレーテツド | Ｇ−ｃｓｆの精製方法 |
| GB8927546D0 (en) | 1989-12-06 | 1990-02-07 | Ciba Geigy | Process for the production of biologically active tgf-beta |
| US5986070A (en) | 1990-04-06 | 1999-11-16 | Amgen Inc. | Production of biologically active NGF proteins |
| AU664021B2 (en) | 1990-09-05 | 1995-11-02 | Natinco Nv | Solubilization of proteins in active forms |
| WO1993018136A1 (en) | 1992-03-05 | 1993-09-16 | Cytomed, Inc. | Process for supporting hematopoietic progenitor cells |
| US5663304A (en) | 1993-08-20 | 1997-09-02 | Genentech, Inc. | Refolding of misfolded insulin-like growth factor-I |
| EP0657466B1 (en) | 1993-11-10 | 1997-01-15 | Pfizer Inc. | A process for refolding of (pro-)chymosin, comprising recycling of urea |
| US5466377A (en) * | 1994-01-19 | 1995-11-14 | Grandics; Peter | Chromatography media and their uses |
| IL113497A0 (en) | 1994-04-28 | 1995-07-31 | Amgen Inc | Method for controlling metallophosphate precipitation in high cell density fermentations |
| AU2603995A (en) | 1994-05-25 | 1995-12-18 | University Of Nebraska Board Of Regents | Biologically active glycoprotein hormones produced in procaryotic cells |
| AU6028396A (en) | 1995-06-07 | 1996-12-30 | Amgen, Inc. | Ob protein compositions and method |
| DE69733950T2 (de) * | 1996-01-23 | 2006-07-06 | Ortho-Mcneil Pharmaceutical, Inc. | Methode zur reinigung eines erythrpoietinbindenden proteins |
| US5935824A (en) * | 1996-01-31 | 1999-08-10 | Technologene, Inc. | Protein expression system |
| US20020052026A1 (en) | 1997-10-08 | 2002-05-02 | Steven M. Vicik | Methods of refolding proteins |
| US6180391B1 (en) | 1998-01-28 | 2001-01-30 | Amgen Inc. | Highly efficient controlled expression of exogenous genes in e. coli |
| US6653098B1 (en) | 1998-02-23 | 2003-11-25 | G. D. Searle & Co. | Method of producing mouse and human endostatin |
| WO1999060120A2 (en) | 1998-05-19 | 1999-11-25 | Avidex Limited | Soluble t cell receptor |
| US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
| JP2003505471A (ja) * | 1999-07-21 | 2003-02-12 | アムジエン・インコーポレーテツド | Ｖｇｆポリペプチドおよびｖｇｆ関連障害の治療方法 |
| US6808902B1 (en) | 1999-11-12 | 2004-10-26 | Amgen Inc. | Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
| IL152804A0 (en) | 2000-05-16 | 2003-06-24 | Bolder Biotechnology Inc | Methods for refolding proteins containing free cysteine residues |
| DE60138715D1 (de) | 2000-09-05 | 2009-06-25 | Amgen Inc | Tnf-rezeptor-ähnliche moleküle und deren anwendungen |
| US20070111944A1 (en) * | 2001-02-16 | 2007-05-17 | Scrofani Sergio D B | Purification of vascular endothelial growth factor-B |
| JP2005505494A (ja) | 2001-02-23 | 2005-02-24 | イミュネックス・コーポレーション | 活性タンパク質の回収増加 |
| US6972327B1 (en) * | 2001-05-08 | 2005-12-06 | Immunex Corporation | Regeneration of chromatography material |
| US7138370B2 (en) | 2001-10-11 | 2006-11-21 | Amgen Inc. | Specific binding agents of human angiopoietin-2 |
| ITMI20012345A1 (it) | 2001-11-08 | 2003-05-08 | Internat Ct For Genetic En Gin | Procedimento per la produzione di interferone alfa di grado terapeutico |
| SI21102A (sl) | 2001-12-19 | 2003-06-30 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Postopek za izolacijo biološko aktivnega granulocitne kolonije stimulirajočega dejavnika |
| AU2002345829A1 (en) | 2002-06-24 | 2004-01-06 | Dr. Reddy's Laboratories Ltd. | Process for preparing g-csf |
| US7067279B1 (en) | 2002-08-23 | 2006-06-27 | Immunex Corporation | Cell culture performance with betaine |
| CN101287484B (zh) | 2002-12-20 | 2012-10-10 | 安姆根有限公司 | 抑制肌肉生长抑制素的结合剂 |
| US7083948B1 (en) | 2002-12-24 | 2006-08-01 | Immunex Corporation | Polypeptide purification reagents and methods for their use |
| EP1449848A1 (en) | 2003-02-20 | 2004-08-25 | GBF German Research Centre for Biotechnology | Method for the production of cystine-knot proteins |
| GB0304068D0 (en) | 2003-02-22 | 2003-03-26 | Avidex Ltd | Substances |
| DE602004026343D1 (de) | 2003-10-24 | 2010-05-12 | Amgen Inc | Verfahren zur aufreinigung von proteinen in einer durchflussfraktion aus der chromatographie mit hydrophoben wechselwirkungen |
| US7781395B2 (en) | 2004-01-30 | 2010-08-24 | Immunex Corporation | Process for purifying proteins |
| WO2005089102A2 (en) | 2004-02-04 | 2005-09-29 | Neose Technologies, Inc. | Methods of refolding mammalian glycosyltransferases |
| US20080124795A1 (en) | 2004-03-10 | 2008-05-29 | Hideyuki Miyake | Vascular Cell Culture Patterning Substrate |
| WO2005092914A1 (en) | 2004-03-22 | 2005-10-06 | Blue Mountain Technology Development Lab | Process for promoting proper folding of human serum albumin using a human serum albumin ligand |
| FR2874318B1 (fr) | 2004-08-19 | 2006-11-24 | Oreal | Utilisation en cosmetique de composes polysaccharidiques amphoteres a chaine(s) polymerique(s) cationique(s) |
| NZ553420A (en) | 2004-08-19 | 2010-02-26 | Biogen Idec Inc | Refolding transforming growth factor beta family proteins |
| DE102004041639A1 (de) * | 2004-08-27 | 2006-03-02 | Bioceuticals Arzneimittel Ag | Verfahren zur Gewinnung von biologisch aktivem humanen G-CSF aus Inclusion Bodies |
| EA011879B1 (ru) | 2004-09-24 | 2009-06-30 | Эмджин Инк. | МОЛЕКУЛЫ С МОДИФИЦИРОВАННЫМ Fc ФРАГМЕНТОМ |
| US7435804B2 (en) | 2004-10-19 | 2008-10-14 | Phage Biotechnology, Inc. | Method for obtaining single chain antibodies to human interferon α2b |
| JP5553963B2 (ja) | 2004-10-22 | 2014-07-23 | アムジエン・インコーポレーテツド | 組換え抗体をリフォールディングする方法 |
| DK1828239T3 (da) | 2004-12-10 | 2011-12-19 | Zymogenetics Inc | FGF18-produktion i prokaryote værter |
| CA2594502A1 (en) | 2005-01-28 | 2006-08-03 | Zymogenetics Inc. | Homogeneous preparations of il-31 |
| WO2006097944A2 (en) | 2005-03-17 | 2006-09-21 | Zenotech Laboratories Limited | Process for the purification of recombinant granulocyte-colony stimulating factor |
| DE102005033250A1 (de) * | 2005-07-15 | 2007-01-18 | Bioceuticals Arzneimittel Ag | Verfahren zur Reinigung von G-CSF |
| US8008453B2 (en) | 2005-08-12 | 2011-08-30 | Amgen Inc. | Modified Fc molecules |
| US7735525B2 (en) | 2005-11-14 | 2010-06-15 | Amgen Inc. | Thermally insulated apparatus for liquid chromatographic analysis |
| WO2007075283A2 (en) | 2005-12-06 | 2007-07-05 | Amgen Inc. | Polishing steps used in multi-step protein purification processes |
| NZ568809A (en) | 2005-12-22 | 2011-08-26 | Genentech Inc | Recovering and purification of VEGF proteins from prokaryotic cells using polyanionic agents |
| EP1845103B1 (en) | 2006-04-10 | 2015-02-25 | Boehringer Ingelheim RCV GmbH & Co KG | Method for refolding a protein |
| JP2009540018A (ja) | 2006-06-13 | 2009-11-19 | ザイモジェネティクス， インコーポレイテッド | Ｉｌ−１７およびｉｌ−２３アンタゴニストならびにその使用方法 |
| US20080125580A1 (en) | 2006-07-14 | 2008-05-29 | Genentech, Inc. | Refolding of Recombinant Proteins |
| EP2049821A4 (en) | 2006-07-21 | 2013-09-04 | Amgen Inc | Rupture valve |
| WO2008097829A2 (en) | 2007-02-02 | 2008-08-14 | Neose Technologies, Inc. | Large scale production of eukaryotic n-acetylglucosaminyltransferase i in bacteria |
| TW201307390A (zh) | 2007-02-02 | 2013-02-16 | Amgen Inc | 海帕西啶（ｈｅｐｃｉｄｉｎ）、海帕西啶拮抗劑及使用方法 |
| WO2008096370A2 (en) | 2007-02-05 | 2008-08-14 | Natco Pharma Limited | An efficient and novel purification method of recombinant hg-csf |
| WO2008100578A2 (en) | 2007-02-14 | 2008-08-21 | Amgen Inc. | Method of isolating antibodies by precipitation |
| US8933197B2 (en) | 2007-08-15 | 2015-01-13 | Amunix Operating Inc. | Compositions comprising modified biologically active polypeptides |
| US20110003337A1 (en) | 2008-02-29 | 2011-01-06 | Ramot At Tel-Aviv University Ltd. | Immunoglobulin compositions and methods of producing same |
| LT3216803T (lt) | 2008-06-25 | 2020-06-10 | Novartis Ag | Stabilūs ir tirpūs antikūnai, slopinantys vegf |
| EA020621B1 (ru) | 2009-06-22 | 2014-12-30 | Амген Инк. | Рефолдинг белков с использованием химически контролируемого окислительно-восстановительного состояния |
| LT3660032T (lt) | 2009-06-25 | 2026-02-25 | Amgen Inc. | Ne žinduolių sistemoje ekspresuotų baltymų surišamojo gryninimo būdai |
| TWI648532B (zh) | 2011-08-29 | 2019-01-21 | 美商安美基公司 | 用於非破壞性檢測-流體中未溶解粒子之方法及裝置 |
| US8945872B2 (en) | 2013-01-25 | 2015-02-03 | Warsaw Orthopedic, Inc. | Methods of purifying human recombinant growth and differentiation factor-5 (rhGDF-5) protein |
| US20160038588A1 (en) | 2013-03-15 | 2016-02-11 | Amgen Inc. | Myostatin Antagonism in Human Subjects |
| US9632095B2 (en) | 2014-12-01 | 2017-04-25 | University Of Delaware | Device and method for determining reaction kinetics |
| US9704239B1 (en) | 2016-09-02 | 2017-07-11 | Amgen Inc. | Video trigger synchronization for improved particle detection in a vessel |
-
2010
- 2010-06-24 LT LTEP19209054.6T patent/LT3660032T/lt unknown
- 2010-06-24 EP EP19209054.6A patent/EP3660032B1/en active Active
- 2010-06-24 US US12/822,990 patent/US8940878B2/en active Active
- 2010-06-24 ES ES19209054T patent/ES3056593T3/es active Active
- 2010-06-24 ES ES10729997T patent/ES2862580T5/es active Active
- 2010-06-24 CA CA2765154A patent/CA2765154A1/en not_active Abandoned
- 2010-06-24 WO PCT/US2010/039854 patent/WO2010151688A2/en not_active Ceased
- 2010-06-24 SI SI201032164T patent/SI3660032T1/sl unknown
- 2010-06-24 DK DK19209054.6T patent/DK3660032T3/da active
- 2010-06-24 JP JP2012517737A patent/JP2012531428A/ja active Pending
- 2010-06-24 AU AU2010266093A patent/AU2010266093B2/en not_active Ceased
- 2010-06-24 EP EP10729997.6A patent/EP2445924B2/en active Active
- 2010-06-24 MX MX2011013417A patent/MX2011013417A/es active IP Right Grant
- 2010-06-24 FI FIEP19209054.6T patent/FI3660032T3/fi active
-
2015
- 2015-01-16 US US14/599,336 patent/US9643997B2/en active Active
-
2017
- 2017-03-31 US US15/476,691 patent/US10577392B2/en active Active
-
2019
- 2019-12-10 US US16/709,491 patent/US11407784B2/en active Active
-
2022
- 2022-07-27 US US17/874,846 patent/US12312381B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012531428A5 (https=) | ||
| FI3660032T3 (fi) | Ei-nisäkäsperäisessä järjestelmässä ekspressoitujen proteiinien sieppauspuhdistusmenetelmiä | |
| US20230072673A1 (en) | C-peptides and proinsulin polypeptides comprising the same | |
| BR112014023869A2 (pt) | proteínas nutritivas carregadas e métodos | |
| EA201591807A1 (ru) | Способы изготовления образцов для контроля содержания с-концевого лизина, галактозы и сиаловой кислоты в рекомбинантных белках | |
| PL1966240T6 (pl) | Peptydy laktoferyny użyteczne jako peptydy penetrujące komórkę | |
| CN103472222B (zh) | 一种长效酶标板稳定剂 | |
| JP2019528255A5 (https=) | ||
| WO2006020935A3 (en) | Stabilizing formulations | |
| Barrett | Human cathepsin D | |
| AR066387A1 (es) | Produccion de proteinas biologicamente activas | |
| CA2888824C (en) | Elution of biomolecules from multi-modal resins using mes as mobile phase modifier | |
| RU2014137623A (ru) | Колоночное ферментативное расщепление | |
| BRPI0509846A (pt) | sistema de expressão para a preparação de proteìnas de fusão de il-15/fc e seu uso | |
| KR102495546B1 (ko) | 생체분자의 수집, 안정화 및 용리를 위한 기재 및 방법 | |
| Nara et al. | Use of zeolite to refold a disulfide-bonded protein | |
| Daniels et al. | In vivo functional assay of a recombinant aquaporin in Pichia pastoris | |
| Singh et al. | Introduction to recombinant protein purification | |
| ATE496133T1 (de) | Affinitätspolypeptid zur reinigung von rekombinanten proteinen | |
| JP2014533495A5 (https=) | ||
| WO2006041849A3 (en) | Methods and compositions for concentrating secreted recombinant protein | |
| Hwang et al. | Refolding of lysozyme in hydrophobic interaction chromatography: effects of hydrophobicity of adsorbent and salt concentration in mobile phase | |
| Rahman et al. | Sarkosyl is a good regeneration reagent for studies on vacuolar-type ATPase subunit interactions in Biacore experiments | |
| Ernst et al. | Concentrating membrane-protein samples for crystallography | |
| Li et al. | Effect of Coconut Water on the Growth of Gluconacetobacter x ylinus Y15 |